CVS Group (LON:CVSG – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported GBX 80.10 earnings per share (EPS) for the quarter, Digital Look Earnings reports. CVS Group had a return on equity of 7.86% and a net margin of 3.20%.
CVS Group Price Performance
CVSG opened at GBX 1,364 on Tuesday. The company has a debt-to-equity ratio of 110.52, a quick ratio of 0.90 and a current ratio of 1.09. The stock has a market capitalization of £978.53 million, a PE ratio of 35,894.74, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The stock’s 50 day moving average price is GBX 1,235.56 and its 200-day moving average price is GBX 1,191.40. CVS Group has a 52-week low of GBX 791 and a 52-week high of GBX 1,382.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on CVSG. Berenberg Bank reissued a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a research note on Tuesday, September 2nd. Royal Bank Of Canada reissued an “outperform” rating and set a GBX 1,500 price target on shares of CVS Group in a research report on Friday, August 29th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, CVS Group currently has a consensus rating of “Buy” and a consensus target price of GBX 1,750.
Insider Buying and Selling
In related news, insider Richard Fairman purchased 1,644 shares of the business’s stock in a transaction that occurred on Friday, July 11th. The shares were acquired at an average price of GBX 1,216 per share, for a total transaction of £19,991.04. 1.38% of the stock is owned by insiders.
CVS Group Company Profile
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Read More
- Five stocks we like better than CVS Group
- What is the Australian Securities Exchange (ASX)
- TrumpRx Brings Pfizer Into the Green—Is It a Buy?
- How to Use the MarketBeat Excel Dividend Calculator
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- Using the MarketBeat Dividend Tax Calculator
- 3 Exceptional Stocks to Build Long-Term Wealth
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.
